News

Novel combination therapy improves treatment outcomes in preclinical lung cancer models

Blood-camouflaged liquid metal nanoparticles defeat the most aggressive breast cancer

Scientists identify molecule driving one of the deadliest forms of breast cancer

How can we reduce gynaecologic cancer–related deaths in low and middle-income countries?

‘Molecular glue’ turns a cancer driver into a built-in kill switch in study

First-in-class therapy targets 'undruggable' protein in hard-to-treat blood cancers

Imaging reveals how a tumour-fighting drug triggers cellular breakdown

Researchers uncovered how loss of NF1 drives ER+ breast cancer to metastasise to the bone

New drug combination may help treat advanced prostate cancer

Study points to broader stem cell donor options for blood cancer patients

Younger adults with lung cancer more likely to have targetable genetic changes, study finds

Mapping gene expression and epigenetic changes that cause 'undead' cancer cells to trigger cancer-promoting inflammation